Статья
Новая техника TABAs в лечении бифуркационных поражений коронарных артерий
Чрескожные коронарные вмешательства (ЧКВ) при бифуркационных стенозах коронарных артерий (КА) по-прежнему считаются технически сложными в выполнении, что, в первую очередь, связано с риском окклюзии боковой ветви. Для бифуркационных стенозов характерны более высокие стоимость выполнения процедуры и частота рестеноза. За последние 10 лет было предложено много различных технологий стентирования бифуркационных стенозов КА. Использование их позволило значительно увеличить частоту непосредственного успеха ЧКВ, а применение стентов с лекарственным покрытием – ощутимо снизить частоту рестеноза. Однако существующим методам присущи недостатки, которые осложняют их выполнение и неблагоприятно влияют на отдаленные результаты. В статье описана оригинальная методика проведения ЧКВ при бифуркационных стенозах, которая получила название TABAs.
1. Оганов Р.Г., Масленникова Г.Я. Профилактика сердечнососудистых заболеваний – реальный путь улучшения демографической ситуации в России. Кардиология 2007;47(1): 4-7.
2. Colombo A, Iakovou I. Ten years of advancements in interventional cardiology. J Endovasc Ther 2004; 11(Suppl 2): II10-8.
3. Беленков Ю.Н., Самко А.Н., Батыралиев Т.А., Першуков И.В. Коронарная ангиопластика: взгляд через 30 лет. Кардиология 2007; 9: 4-14.
4. Iakovou I, Sangiorgi GM, Stankovic G, et al. Effectiveness of sirolimus-eluting stent implantation for treatment of in-stent restenosis after brachytherapy failure. Am J Cardiol 2004; 94: 351-4.
5. Cohen DJ, Bakhai A, Shi C, et al. Cost-effectiveness of sirolimuseluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients with De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation 2004; 110: 508-14.
6. Colombo A, Iakovou I. Drug-eluting stents: the new gold standard for percutaneous coronary revascularisation. Eur Heart J 2004; 25: 895-7.
7. Batyraliev T, Avsar O. Coronary in-stent restenosis and drugeluting stents. The Tur J Inv Cardiol 2007; 11(4): 163-9.
8. Iakovou I, Ge L, Michev I, et al. Clinical and angiographic outcome after sirolimus-eluting stent implantation in aortoostial lesions. JACC 2004; 44: 967-71.
9. Moses JW, Leon MB, Popma JJ, et al, Kuntz RE, SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-23.
10. Yamashita T, Nishida T, Adamian MG, et al. Bifurcation lesions: two stents versus one stent – immediate and follow-up results. JACC 2000; 35: 1145-51.
11. Hoye A, Lemos PA, Aoki J, et al. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. Am J Cardiol 2004; 94(1): 115-8.
12. Anzuini A, Briguori C, Rosanio S, et al. Immediate and long-term clinical and angiographic results from Wiktor stent treatment for true bifurcation narrowings. Am J Cardiol 2001; 88: 1246-50.
13. Al Suwaidi J, Berger PB, Rihal CS, et al. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. JACC 2000; 35: 929-36.
14. Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the real world: The rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 2004; 109(2): 190-5.
15. Pan M, Suarez de Lezo J, Medina A, et al. Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin. Am J Cardiol 1999; 83: 1320-5.
16. Chevalier B, Glatt B, Royer T, Guyon P. Placement of coronary stents in bifurcation lesions by the “culotte” technique. Am J Cardiol 1998; 82: 943-9.
17. Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004; 109: 1244-9.
18. Jamgyrchiev S, Fetcer DV, Pershukov IV, et al. Clinical impact of drug-eluting coronary stents. The Turkish Journal of Invasive Cardiology 2006; 10(4): 166-72.
19. Iakovou I, Ge L, Colombo A. Contemporary stent treatment of coronary bifurcations. JACC 2005; 46: 1446-55.
20. Ozgul S, Batyraliev T, Sercelik A, et al. The use of drug-eluting stents in single and multivessel disease: Results from our centre experience. The Tur J Inv Cardiol 2005; 9(1): 1-12.
21. Fort S, Lazzam C, Schwartz L. Coronary ‘Y’ stenting: a technique for angioplasty of bifurcation stenoses. Can J Cardiol 1996; 12: 678-82.
22. Kobayashi Y, Colombo A, Akiyama T, et al. Modifed «T» stenting: a technique for kissing stents in bifurcational coronary lesion. Cath Cardiovasc Diagn 1998; 43: 323-6.
23. Carrie D, Karouny E, Chouairi S, Puel J. “T”-shaped stent placement: a technique for the treatment of dissected bifurcation lesions. Cath Cardiovasc Diagn 1996; 37: 311-3.
24. Pan M, Suarez de Lezo J, Medina A, et al. A stepwise strategy for the stent treatment of bifurcated coronary lesions. Cath Cardiovasc Interv 2002; 55: 50-7.
25. Ormiston JA, Webster MW, Ruygrok PN, Stewart JT, White HD, Scott DS. Stent deformation following simulated side-branch dilatation: a comparison of five stent designs. Cath Cardiovasc Interv 1999; 47: 258-64.
26. Colombo A, Stankovic G, Orlic D, et al. Modifed T-stenting technique with crushing for bifurcation lesions: immediate results and 30-day outcome. Cath Cardiovasc Interv 2003; 60: 145-51.
27. Colombo A. Bifurcational lesions and the “crush” technique: understanding why it works and why it doesn’t – a kiss is not just a kiss. Cath Cardiovasc Interv 2004;63:337–8.
28. Schampaert E, Fort S, Adelman AG, Schwartz L. The V-stent: a novel technique for coronary bifurcation stenting. Cath Cardiovasc Diagn 1996; 39: 320-6.
29. Colombo A, Gaglione A, Nakamura S, Finci L. “Kissing” stents for bifurcational coronary lesion. Cath Cardiovasc Diagn 1993; 30: 327-30.
30. Ge L, Airoldi F, Iakovou I, et al. Clinical and angiographic outcome following implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilatation. JACC 2005; 46: 613-20.
31. Ge L, Tsagalou E, Iakovou I, et al. In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent. Am J Cardiol 2005;95:75760.
32. Ormiston JA, Currie E, Webster MW, et al. Drug-eluting stents for coronary bifurcations: Insights into the crush technique. Cath Cardiovasc Interv 2004; 63: 332-6.
33. Sianos G, Vaina S, Hoya A, Serruys PW. Bifurcation stenting with drug-eluting stents: illustration of the crush technique. Cath Cardiovasc Interv 2006; 67(6): 839-45.
34. Kim YH, Park SW, Hong MK, et al. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am J Cardiol 2006; 97(11): 1597-601. Epub 2006 Apr 7.
35. Collins N, Dzavik V. A modified balloon crush approach improves side branch access and side branch stent apposition during crush stenting of coronary bifurcation lesions. Cath Cardiovasc Interv 2006; 68(3): 365-71.
36. Sharma SK, Kini AS. Coronary bifurcation lesions. Cardiol Clin 2006; 24(2): 233-46, vi.
37. Costa RA, Moussa ID. Percutaneous treatment of coronary bifurcation lesions in the era of drug-eluting stents. Minerva Cardioangiol 2006; 54(5): 577-89.
38. Батыралиев Т.А., Фетцер Д.В., Преображенский Д.В., Сидоренко Б.А. Проблема осложнений при чрескожных коронарных вмешательствах. Часть I. Характер и частота осложнений. Кардиология 2008; 48(1): 81-7.
39. Lagerqvist B, James SK, Stenestrand U, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007; 356: 1009-19.
40. Nakamura S, Hall P, Maiello L, Colombo A. Techniques for Palmaz-Schatz stent deployment in lesions with a large side branch. Cath Cardiovasc Diagn 1995; 34: 353-61.
41. Alberti A, Missiroli B, Nannini C. ‘‘Skirt’’ technique for coronary artery bifurcation stenting. J Invasiv Cardiol 2000; 12: 633-6.
42. Hoye A, Iakovou I, Ge L, et al. Long-term outcomes after stenting of bifurcation lesions with the ‘‘crush’’ technique: predictors of an adverse outcome. JACC 2006; 47: 1949-58.
43. Carlson TA, Guarneri EM, Stevens KM, et al. ‘‘T-stenting’’: The answer to bifurcation lesions? Circulation 1996; 94: I86-7.
44. Karvouni E, Di Mario C, Nishida T, et al. Directional atherectomy prior to stenting in bifurcation lesions: a matched comparison study with stenting alone. Cath Cardiovasc Interv 2001; 53: 12-20.
45. Batyraliev T, Konukoglu O, Vural A, Demirbas O. Three angle bifurcation angioplasty and stenting. The Turk J Invasiv Cardiol 2006; 10(4): 180-3.
46. Khoja A, Ozbek C, Bay W, Heisel A. Trouser-like stenting: a new technique for bifurcation lesions. Cath Cardiovasc Diagn 1997; 41: 192-6; discussion 197-9.
47. Spokojny AM, Sanborn TM. The bifurcation lesion. In: Ellis SG, Holmes DR Jr., editors. Strategic Approaches in Coronary Intervention. Baltimore, MD: Williams and Wilkins, 1996; 288.
48. Lefevre T, Louvard Y, Morice MC, et al. Stenting of bifurcation lesions: classifcation, treatments, and results. Cath Cardiovasc Interv 2000; 49: 274-83.